403 related articles for article (PubMed ID: 21563983)
1. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
Ogris M; Wagner E
Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
[TBL] [Abstract][Full Text] [Related]
2. Functional polymers for targeted delivery of nucleic acid drugs.
Mok H; Park TG
Macromol Biosci; 2009 Aug; 9(8):731-43. PubMed ID: 19655399
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in non-viral nucleic acids delivery.
Salem AK; Patil SD; Burgess DJ
Int J Pharm; 2012 May; 427(1):1-2. PubMed ID: 22143087
[No Abstract] [Full Text] [Related]
4. A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery.
Wang XL; Jensen R; Lu ZR
J Control Release; 2007 Jul; 120(3):250-8. PubMed ID: 17582638
[TBL] [Abstract][Full Text] [Related]
5. Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.
Hsu CY; Uludağ H
J Drug Target; 2012 May; 20(4):301-28. PubMed ID: 22303844
[TBL] [Abstract][Full Text] [Related]
6. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
Wagner E; Kircheis R; Walker GF
Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
[TBL] [Abstract][Full Text] [Related]
7. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
8. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
Deshayes S; Morris M; Heitz F; Divita G
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in carbohydrate-decorated targeted drug/gene delivery.
Zhang H; Ma Y; Sun XL
Med Res Rev; 2010 Mar; 30(2):270-89. PubMed ID: 19626595
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution for drug and nucleic acid delivery.
Hida K; Hanes J; Ostermeier M
Adv Drug Deliv Rev; 2007 Dec; 59(15):1562-78. PubMed ID: 17933418
[TBL] [Abstract][Full Text] [Related]
11. Cationic lipids and polymers mediated vectors for delivery of siRNA.
Zhang S; Zhao B; Jiang H; Wang B; Ma B
J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
[TBL] [Abstract][Full Text] [Related]
12. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
Vorhies JS; Nemunaitis J
Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.
Snyder EL; Dowdy SF
Expert Opin Drug Deliv; 2005 Jan; 2(1):43-51. PubMed ID: 16296734
[TBL] [Abstract][Full Text] [Related]
14. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy.
Hallaj-Nezhadi S; Lotfipour F; Dass CR
Pharmazie; 2010 Dec; 65(12):855-9. PubMed ID: 21284252
[TBL] [Abstract][Full Text] [Related]
15. siRNA delivery systems for cancer treatment.
Oh YK; Park TG
Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
[TBL] [Abstract][Full Text] [Related]
16. Peptide-mediated delivery of nucleic acids into mammalian cells.
Deshayes S; Simeoni F; Morris MC; Divita G; Heitz F
Methods Mol Biol; 2007; 386():299-308. PubMed ID: 18604951
[TBL] [Abstract][Full Text] [Related]
17. Advances in cancer gene therapy: tumor-targeted delivery of therapeutic pDNA, siRNA, and dsRNA nucleic acids.
Wagner E
J BUON; 2007 Sep; 12 Suppl 1():S77-82. PubMed ID: 17935282
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
Kuruba R; Wilson A; Gao X; Li S
AAPS J; 2009 Mar; 11(1):23-30. PubMed ID: 19132538
[TBL] [Abstract][Full Text] [Related]
19. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
[TBL] [Abstract][Full Text] [Related]
20. SiRNA delivery: challenges and role of carrier systems.
Shegokar R; Al Shaal L; Mishra PR
Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
